DrugSupplement
Polyphenon E clinical trials
Also written Polyphenon E and Veregen.
- studies test it
- 32
- open now
- 0
- in phase 3
- 2
- first study started
- 2004
How studies write it
Studies that test it under each name
Studies by the year they started
32 studies that test it; most in 2004 (5)
| Year | Studies |
|---|---|
| 2004 | 5 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 10
- Phase 2
- 19
- Phase 3
- 2
- Phase 4
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 30
National Cancer Institute (NCI) (6) · Louisiana State University Health Sciences Center Shreveport (3) · Louisiana State University Health Sciences Center in New Orleans (2) · Mayo Clinic (2) · MediGene (2) · British Columbia Cancer Agency (2) · ECOG-ACRIN Cancer Research Group (1) · Hospital Universitari Vall d'Hebron Research Institute (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses polyphenon E is read from its arms, and is right about nine times in ten.
Testing it · 32
- To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close MonitoringActive, not recruitingPhase 2ECOG-ACRIN Cancer Research GroupNCT04597359Written as Sinecatechins
- Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With CirrhosisActive, not recruitingPhase 1National Cancer Institute (NCI)NCT03278925Written as Defined Green Tea Catechin Extract
- Clinical Trial for Evaluating the Efficacy and Safety of Electrocoagulation vs Topic Sinecatechins vs Topic Cidofovir Within the Treatment to High-grade Anal Intraepithelial Neoplasia in HIV Homosexual MalesCompletedPhase 3Hospital Universitari Vall d'Hebron Research InstituteNCT04055142Written as sinecatechins 10% topical ointment
- Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected IndividualsCompletedPhase 1Baylor College of MedicineNCT01433289Written as Polyphenon E
- Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug TreatmentTerminatedPhase 2GTO Pharmaceutical, LLCNCT03682601Written as 5% sinecatechins ointment
- Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder CancerCompletedPhase 2Jonsson Comprehensive Cancer CenterNCT00088946Written as Polyphenon E
- A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in SituTerminatedPhase 2University of ChicagoNCT01060345Written as Polyphenon E
- Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial NeoplasiaCompletedPhase 2H. Lee Moffitt Cancer Center and Research InstituteNCT00596011Written as Polyphenon E
- Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% OintmentCompletedNot applicableIcahn School of Medicine at Mount SinaiNCT02147353Written as Sinecatechins 15% Ointment
- Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative ColitisCompletedPhase 2University of LouisvilleNCT00718094Written as Polyphenon E®
- Green Tea Extract in Treating Patients With Nonmetastatic Bladder CancerCompletedPhase 2National Cancer Institute (NCI)NCT00666562Written as Defined Green Tea Catechin Extract
- Polyphenon E in Treating Patients With High-Risk of Colorectal CancerTerminatedPhase 2Mayo ClinicNCT01606124Written as defined green tea catechin extract
- A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer ProgressionCompletedPhase 2Louisiana State University Health Sciences Center ShreveportNCT00676793Written as Polyphenon E
- Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate CancerCompletedNot applicableOHSU Knight Cancer InstituteNCT00253643Written as green tea catechin extract
- Topical Green Tea Ointment in Treatment of Superficial Skin CancerCompletedPhase 2/3Maastricht University Medical CenterNCT02029352Written as Sinecatechins 10%
- Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial NeoplasiaCompletedPhase 2National Cancer Institute (NCI)NCT00303823Written as defined green tea catechin extract
- Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung CancerTerminatedPhase 1Louisiana State University Health Sciences Center ShreveportNCT00707252Written as Polyphenon E
- Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple MyelomaTerminatedPhase 2Barbara Ann Karmanos Cancer InstituteNCT00942422Written as defined green tea catechin extract
- Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the ProstateCompletedPhase 1National Cancer Institute (NCI)NCT00459407Written as defined green tea catechin extract
- Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast CancerCompletedPhase 1National Cancer Institute (NCI)NCT00516243Written as defined green tea catechin extract
Codes
What other systems call polyphenon E · ClinicalTrials.gg INT004514
- MeSH (NLM) C472086polyphenon EOne source NLM
- UNII (FDA) T432289GYZSINECATECHINSConfirmed FDA, NLM
- RxNorm 753346One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C472086 | polyphenon E | One source NLM |
| UNII (FDA) | T432289GYZ | SINECATECHINS | Confirmed FDA, NLM |
| RxNorm | 753346 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.